Personalised app for diabetes launched by Novo to aid management of the condition

The digital health deal between Novo Nordisk’s and Glooko produced a new diabetes management app, C4C that they hope will assist users to better manage the condition. The C4C app also includes relevant content and resources from Novo’s Cornerstones4Care personalised support programme. David Moore, senior vice president of marketing at Novo Nordisk, said: “In today’s

Continue Reading

The digital doctor-patient relationship

Written by James Selvey, an account manager at Grey Health London As of this year, doctors and patients are digitally engaged, from obtaining information or to have access to tools to help diagnose, manage, maintain adherence, or simply to stay ‘well aware’ via wearables and health data. Doctors are a few clicks away from accessing

Continue Reading

London Healthcare Hub launched by Pfizer to aid healthtech start-ups

Pfizer announces launch of ‘Pfizer Healthcare Hub: London’, a project that aims to help start-ups, focusing on the development of technology in healthcare, to ‘reach more patients and providers’. Pfizer will provide both funding and networking support to ‘late-stage’ start-ups, whilst focusing on companies developing tech such as devices, apps, wearables, artificial reality and virtual

Continue Reading

Novo Nordisk and Glooko collaborate to develop digital health solutions for diabetes patients

Novo Nordisk and Glooko have announced that they will work together to deliver jointly-developed and branded digital health solutions for people with diabetes. The non-exclusive collaboration will combine Novo Nordisk’s deep knowledge of diabetes with Glooko’s digital platform and data expertise. Building upon Glooko’s mobile and web platforms, the companies aim to deliver personalised services

Continue Reading

GSK and Propeller Health’s smart inhaler aims to improve adherence in COPD trials

GlaxoSmithKline’s plans to incorporate sensors in its inhalers is expected to provide real-time data about the patient experience in a clinical trial, and that may help improve adherence. In November the FDA cleared GSK and Propeller Health to market a custom Propeller sensor with Ellipta, the drugmaker’s COPD medication, for the treatment of asthma and

Continue Reading